Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00193180
Status:
COMPLETED
Last Update Posted:
2016-05-27
First Post:
2005-09-12
Brief Title:
Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
Sponsor:
SCRI Development Innovations LLC
Organization:
SCRI Development Innovations LLC